Government of Canada signs bilateral agreement with Alberta to improve access to drugs for rare diseases

5 December 2024 - Today, the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Adriana LaGrange, Alberta's Minister ...

Read more →

Canada’s Drug Agency announces recipients of funding to enhance rare disease registries

21 October 2024 - Canada’s Drug Agency is pleased to announce the successful applicants from our 2024 Request for Proposals (RFP) ...

Read more →

Collaborating to help improve access to drugs for rare diseases

29 February 2024 - On Rare Disease Day — a day when the international community raises awareness about rare conditions ...

Read more →

Investments to support access to drugs for rare diseases

22 March 2023 - Today, the Government announced a total investment of up to $1.5 billion over three years in ...

Read more →

Government of Canada improves access to affordable and effective drugs for rare diseases

22 March 2023 - Today, the Honourable Jean-Yves Duclos, Minister of Health, announced measures in support of the first-ever National Strategy ...

Read more →

Ontario family forced to fight for life-saving drug highlights need for national rare disease strategy

21 April 2022 - Beth Vanstone doesn’t want anyone else to have to fight for access to life saving medications. ...

Read more →

It’s time to better support the three million Canadians with a rare disease

25 November 2021 - After finding out her private health insurer would no longer pay for a drug helping with ...

Read more →

Rare disease patient advocates continue battle for affordable drugs

23 June 2021 - Beth Vanstone, mother of local Cystic Fibrosis Warrior Madi Vanstone and director of the CF Get ...

Read more →

Rare disease drugs strategy, standard coverage in CLHIA’s 2020 budget wish list

12 August 2020 - The Canadian Life and Health Insurance Association is recommending the federal government develop a strategy for ...

Read more →

This drug can treat 90 per cent of cystic fibrosis patients, but it's not available in Canada

19 June 2020 - Struggling to breathe is one of the main symptoms of the novel coronavirus that has recently ...

Read more →

Patients in the 'Fight for Our Lives' call on Parliament to STOP the PMPRB!

10 March 2020 - As the world comes together to fight coronavirus, Canadians with life-threatening rare and common diseases are ...

Read more →

Canadian drug price regulator may be flexible on rare diseases

14 August 2019 - Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in ...

Read more →

Ottawa’s drug-pricing changes threaten Canadians who suffer from rare diseases

28 August 2018 - The federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians with cystic ...

Read more →

Canada trails US in patient access to rare disease therapies, CORD President says

6 June 2018 - Canada’s healthcare system is excellent for people with common ailments like diabetes or high blood pressure, ...

Read more →

Price and clinical factors impact Canadian orphan drug recommendation rates

11 March 2018 - Canada’s Common Drug Review (CDR), which provides recommendations on public payer reimbursement for all non-oncology drugs, ...

Read more →